Share chart Orgenesis Inc.
Extended chart
Simple chart
About Orgenesis Inc.
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. more details| IPO date | 2012-03-12 |
|---|---|
| ISIN | US68619K2042 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.orgenesis.com |
| Цена ао | 0.8511 |
| Change price per day: | -2.07% (2.9) |
|---|---|
| Change price per week: | +118.46% (1.3) |
| Change price per month: | +134.71% (1.21) |
| Change price per 3 month: | -46.42% (5.3) |
| Change price per half year: | -54.78% (6.281) |
| Change price per year: | +468% (0.5) |
| Change price per 3 year: | -5.33% (3) |
| Change price per 5 year: | -9.55% (3.14) |
| Change price per 10 year: | 0% (2.84) |
| Change price per year to date: | +136.67% (1.2) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard Group Inc | 924806 | 5.92 |
| Knoll Capital Management, LLC | 634738 | 4.06 |
| Geode Capital Management, LLC | 239264 | 1.53 |
| Blackrock Inc. | 127759 | 0.82 |
| State Street Corporation | 88659 | 0.57 |
| Northern Trust Corporation | 39122 | 0.25 |
| Renaissance Technologies, LLC | 38799 | 0.25 |
| Bank Hapoalim B.M. | 32052 | 0.21 |
| Chapin Davis, Inc. | 20000 | 0.13 |
| Cambridge Investment Research Advisors Inc. | 18330 | 0.12 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Vered Caplan M.Sc. | Chairperson of the Board, CEO & President | 341.38k | 1969 (56 years) |
| Prof. Sarah Ferber Ph.D. | Founder & Chief Scientific Officer | 268.32k | 1954 (71 year) |
| Dr. Shimon Hassin Ph.D. | Chief Technology Officer | N/A | |
| Mr. Victor Miller | CFO, Secretary & Treasurer | N/A | 1970 (55 years) |
| Pierre Lammeretz | Interim Chief Operating Officer | N/A | |
| Mr. Joseph Carpinelli | Chief Financial Officer of Octomera | N/A |
Address: United States, Germantown. MD, 20271 Goldenrod Lane - open in Google maps, open in Yandex maps
Website: https://www.orgenesis.com
Website: https://www.orgenesis.com
